Clinical Trial Update: A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intramuscular injections of human placenta-derived cells (PDA-002) for diabetic peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• PDA-002 (human placenta-derived cells) (PDA-002)

Snippet

Sponsor: Celularity Incorporated | Conditions: Diabetic Nephropathies, Peripheral Nervous System Diseases | Phase 2 | Status: COMPLETED